We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Cytogen and Advanced Magnetics Call Off Merger

By HospiMedica staff writers
Posted on 06 Sep 2000
Advanced Magnetics (Cambridge, MA, USA) and biopharmaceutical company Cytogen Corp. More...
(Princeton, NJ, USA) have announced the mutual termination of Cytogen's agreement to acquire Advanced Magnetics for US$60 million in stock. Instead, the two companies will enter into marketing, license, and supply agreements. Cytogen will acquire certain product rights to Advanced Magnetics' imaging agents in exchange for two million shares of stock. Cytogen will have exclusive U.S. rights to Combidex, a magnetic resonance imaging contrast agent for the detection of lymph node metastases. Cytogen will also have exclusive U.S. rights to imaging agent Code 7228 for oncology applications and the right of first negotiation for applications outside surgery.

Advanced Magnetics will be responsible for all costs associated with the clinical development, supply, and manufacture of Combidex and Code 7228. In addition to supplying Cytogen with these products, Advanced Magnetics will receive royalties based on product sales.

Both Cytogen and Advanced Magnetics agreed that the advantages of a marketing and supply arrangement outweighed the near-term benefits of the merger, said H. Joseph Reiser, Ph.D., president and CEO of Cytogen. In our opinion, Advanced Magnetics' product candidates provide critical information regarding the detection of metastatic cancer which is anticipated to address an unmet medical need in cancer detection and staging.

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Gold Member
12-Channel ECG
CM1200B
New
Syringe Pump
SP50 Series
New
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Even though the team’s new bioelectronic is only about the size of a fingertip, it could offer an effective and biocompatible approach to addressing high blood pressure (photo courtesy of Tao Zhou/Penn State)

Stretchable Bioelectronic Implant Lowers Blood Pressure in Preclinical Study

Hypertension, or high blood pressure, drives major cardiovascular morbidity and affects nearly half of adults in the United States. About one in ten patients develop drug‑resistant hypertension that persists... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.